AKT1 and Cerebral ischemia: Through the pathway enrichment analysis, we found that the targets of active ingredients in HH against cerebral ischemia injury mainly participate in numerous signal transduction pathways such as TNF signaling pathway, toll-like receptor signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway, and VEGF signaling pathway.